
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded antiperspirant cream containing aluminum chlorohydrate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing aluminum chlorohydrate is listed. Products containing it are filed in the directory as over-the-counter monograph drugs, in cream, aerosol, stick, liquid and spray forms.
This dose form is water-containing (aqueous). Under USP <795>, aqueous preparations carry shorter default beyond-use dates than nonaqueous ones, and a preservative in the base allows a longer date than no preservative. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Aluminum chlorohydrate is an aluminum compound used as the active ingredient in over-the-counter antiperspirants that a pharmacy may compound when a prescriber orders it.
Aluminum chlorohydrate (ACH) is one of the aluminum compounds FDA permits as an active ingredient in over-the-counter antiperspirants, which federal rules define as products applied to the skin that reduce sweat production where they are applied. The National Cancer Institute explains that these aluminum compounds form a temporary plug in the sweat duct that keeps sweat from reaching the skin surface. ACH is listed in the antiperspirant rules at 21 CFR part 350 and in OTC monograph M019, and it is sold in aerosol and nonaerosol forms, such as roll-ons, labeled to reduce underarm wetness. It is not an FDA-approved prescription drug: a Drugs@FDA search through openFDA returned no applications naming it. A prescriber might order aluminum chlorohydrate compounded in a vehicle or form that is not sold over the counter. Compounded preparations are not FDA-approved and require a prescription.
Aluminum chlorohydrate has no prescription drug label and no boxed warning. The monograph requires antiperspirant labels to say: do not use on broken skin, stop use if rash or irritation occurs, and ask a doctor before use if you have kidney disease. Drug Facts labels also say for external use only. Aerosol labels must also say to keep the spray away from the face and mouth to avoid breathing it. Keep it out of reach of children, and get medical help or call Poison Control if it is swallowed. The National Cancer Institute states that no scientific evidence links antiperspirant use to breast cancer. No drug interactions were found in the sources used. No LactMed record or pregnancy data were found; if you are pregnant or breastfeeding, talk to your prescriber or pharmacist before use. Talk to your prescriber or pharmacist about side effects.
Antiperspirant aluminum salts reduce sweating at the site of application by forming a temporary plug within the sweat duct. Systemic exposure from underarm use appears small: in a preliminary study in two adults, aluminum-26 labeled ACH applied to one underarm showed absorption of only 0.012% of the applied aluminum, which the authors estimated at about 2.5% of the aluminum typically absorbed from food over the same period, and they concluded that a single use is not a significant contribution to body burden. Regulatory status: ACH is listed as an antiperspirant active ingredient in OTC monograph M019 (section M019.10(b)), with concentration calculated on an anhydrous basis, and it is permitted in both aerosol and nonaerosol forms; by contrast, aluminum chloride is limited to aqueous nonaerosol solutions. Required labeling limits the use to reducing underarm wetness or sweating and directs "apply to underarms only," so application at other sites falls outside monograph labeling. No Drugs@FDA application and no prescription indication exist. Dosing is per prescriber. Ask about kidney disease before use, as the monograph warning requires, and monitor for local irritation or rash, stopping use if either occurs. Aluminum chlorohydrate is not a controlled substance.
Wash your hands. Apply the amount on your label to clean, dry skin and rub it in gently. For a metered pump, each press delivers a set amount; your label states how many presses. For transdermal creams, apply to the area your label names and let it dry before dressing. Wash your hands afterward and avoid skin-to-skin contact with others at the application site until it has absorbed. Do not apply to broken skin unless told to.
Creams are aqueous. Under USP <795>, a preserved cream usually carries a beyond-use date of up to 35 days at room temperature or refrigerated, and an unpreserved one 14 days refrigerated. Follow the storage line on your label, keep from freezing, keep out of reach of children, and discard after the beyond-use date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically